Drug Shortage Report for GD-ELETRIPTAN
Report ID | 130219 |
Drug Identification Number | 02342235 |
Brand name | GD-ELETRIPTAN |
Common or Proper name | ELETRIPTAN |
Company Name | UPJOHN CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | ELETRIPTAN |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 1x6 |
ATC code | N02CC |
ATC description | ANTIMIGRAINE PREPARATIONS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2020-12-21 |
Actual start date | |
Estimated end date | |
Actual end date | 2021-01-11 |
Shortage status | Resolved |
Updated date | 2021-01-12 |
Company comments | |
Health Canada comments | |
Contact Address | 17300 TRANS CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-833-287-5646 Email / courriel: UpjohnCanadaCustomerService@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.